Impact on guidelines: The general practitioner point of view

Sadeleştirilmiş öğe sayfası
dc.contributor.authorCos, X.
dc.contributor.authorSeidu, S.
dc.contributor.authorBrunton, S.
dc.contributor.authorHarris, S. B.
dc.contributor.authorJansson, S. P. O.
dc.contributor.authorMata\\-Cases, M.
dc.contributor.authorNeijens, A. M. J.
dc.contributor.authorTopsever, P.
dc.contributor.authorKhunti, K.
dc.date.accessioned2025-10-16T15:21:05Z
dc.date.issued2020
dc.identifier.doi10.1016/j.diabres.2020.108091
dc.identifier.otherWOS:000572845000038
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7608
dc.publisherELSEVIER IRELAND LTD
dc.sourceDIABETES RESEARCH AND CLINICAL PRACTICE
dc.subjectType 2 diabetes
dc.subjectCardiovascular disease
dc.subjectCardiovascular risk factors
dc.subjectTherapeutic inertia
dc.subjectHeart failure
dc.subjectPrimary care
dc.subjectChronic kidney disease
dc.titleImpact on guidelines: The general practitioner point of view
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS